Why the study?
Do ACE inhibitors improve survival and reduce hospital admissions in patients with chronic congestive heart failure or acute myocardial infarction?
Population
Patients with chronic congestive heart failure or acute myocardial infarction
Design
Review
Authors
Loading...
Supports ACE inhibitor use in HF and post-MI; extends prior trial evidence while leaving implementation gaps open.
Do ACE inhibitors improve survival and reduce hospital admissions in patients with chronic congestive heart failure or acute myocardial infarction?
ACE inhibitors are life-prolonging drugs that improve survival and reduce hospitalizations in patients with heart failure and post-myocardial infarction, though they remain underutilized in primary care.
William D. Linn (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: